The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
about
Molecular characterization of HCV in a Swedish county over 8 years (2002-2009) reveals distinct transmission patterns.Hepatitis C disease transmission and treatment uptake: impact on the cost-effectiveness of new direct-acting antiviral therapies.Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence?: The case of Greece.New era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs).The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence.Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program.Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden.Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway.Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe".Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study.The effect of the first-generation HCV-protease inhibitors boceprevir and telaprevir and the relation to baseline NS3 resistance mutations in genotype 1: experience from a small Swedish cohort.Cost of illness of hepatocellular carcinoma in Japan: A time trend and future projections.
P2860
Q36554870-F401DFDA-E51B-44A2-81FD-95FB69B26366Q38800572-EECA90F9-771B-4068-8E17-884E0445664BQ38842781-926E82EE-3E70-43F9-87AB-E45DDC6042FBQ39016874-E2033759-A11E-446B-AA66-2AA41CF9D914Q39481703-8F3E4ADE-165F-4ADA-B1DA-206D7CDDB228Q40176014-D9B3DA89-9215-4874-9FD2-471B0D39FB5EQ40550798-35308C63-8CC9-4DB0-A1A3-FE8F6BAA3DEAQ41711879-840C2519-B232-4F01-AC1E-39718C626AEBQ46084794-EC3AEE36-C874-42DA-A3C6-43F7D3CFEC81Q47547903-DADD20F7-8D52-44F8-9C1B-C5A942338C6DQ52656603-81A2A72C-E6B5-472F-8A4A-7306550E8D68Q55349731-433823C3-3E60-4501-BECA-1430F1E4668E
P2860
The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
The future disease burden of h ...... ifferent treatment strategies.
@en
The future disease burden of h ...... ifferent treatment strategies.
@nl
type
label
The future disease burden of h ...... ifferent treatment strategies.
@en
The future disease burden of h ...... ifferent treatment strategies.
@nl
prefLabel
The future disease burden of h ...... ifferent treatment strategies.
@en
The future disease burden of h ...... ifferent treatment strategies.
@nl
P2093
P2860
P50
P1476
The future disease burden of h ...... ifferent treatment strategies.
@en
P2093
Ann-Sofi Duberg
Karolin Falconer
Martin Kåberg
P2860
P304
P356
10.3109/00365521.2014.990505
P577
2014-12-17T00:00:00Z